HUTCHMED China Financials
| HCM Stock | 227.00 6.00 2.58% |
HUTCHMED | Select Account or Indicator |
Understanding current and past HUTCHMED China Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of HUTCHMED China's financial statements are interrelated, with each one affecting the others. For example, an increase in HUTCHMED China's assets may result in an increase in income on the income statement.
Please note, the presentation of HUTCHMED China's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, HUTCHMED China's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of HUTCHMED China's management manipulating its earnings.
HUTCHMED China Stock Summary
HUTCHMED China competes with GreenX Metals, Monks Investment, Beeks Trading, AMG Advanced, and First. HUTCHMED China is entity of United Kingdom. It is traded as Stock on LSE exchange.| Foreign Associate | USA |
Specialization | Health Care, Pharmaceuticals, Biotechnology & Life Sciences |
| Instrument | UK Stock View All |
| Exchange | London Exchange |
| ISIN | KYG4672N1198 |
| Business Address | Cheung Kong Center, |
| Sector | Pharmaceuticals |
| Industry | Health Care |
| Benchmark | Dow Jones Industrial |
| Website | www.hutch-med.com |
| Phone | 852 2121 8200 |
You should never invest in HUTCHMED China without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of HUTCHMED Stock, because this is throwing your money away. Analyzing the key information contained in HUTCHMED China's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
HUTCHMED China Key Financial Ratios
There are many critical financial ratios that HUTCHMED China's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that HUTCHMED China reports annually and quarterly.| Revenue | 838 M | ||||
| Gross Profit | (47.45 M) | ||||
| EBITDA | 67.27 M | ||||
| Net Income | 101.09 M | ||||
| Total Asset | 1.28 B |
HUTCHMED China Key Balance Sheet Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Total Assets | 724.1M | 1.4B | 1.0B | 1.3B | 1.5B | 1.5B | |
| Other Current Liab | 122.9M | 228.0M | 278.0M | 329.0M | 378.4M | 397.3M | |
| Net Debt | (199.9M) | (343.5M) | (290.0M) | (197.5M) | (177.7M) | (168.8M) | |
| Retained Earnings | (415.6M) | (610.3M) | (971.5M) | (870.9M) | (783.8M) | (744.6M) | |
| Accounts Payable | 31.6M | 41.2M | 71.1M | 36.3M | 41.8M | 23.2M | |
| Cash | 235.6M | 377.5M | 313.3M | 283.6M | 326.1M | 342.4M | |
| Other Assets | 19.4M | 18.2M | 27.4M | 31.1M | 35.8M | 37.6M | |
| Net Receivables | 47.9M | 83.6M | 98.0M | 116.9M | 134.4M | 141.1M | |
| Good Will | 3.2M | 3.1M | 3.3M | 3.4M | 3.0M | 3.9M | |
| Inventory | 19.8M | 35.8M | 56.7M | 50.3M | 57.8M | 60.7M | |
| Other Current Assets | 24.1M | 78.3M | 51.9M | 40.7M | 46.8M | 28.0M | |
| Total Liab | 205.2M | 333.1M | 392.6M | 536.4M | 616.8M | 647.7M | |
| Total Current Assets | 530.7M | 1.2B | 839.9M | 1.1B | 1.3B | 1.3B | |
| Short Term Debt | 2.8M | 26.9M | 3.7M | 35.1M | 40.3M | 42.4M | |
| Intangible Assets | 347K | 275K | 227K | 163K | 146.7K | 139.4K | |
| Common Stock | 72.8M | 86.5M | 86.5M | 87.1M | 100.2M | 68.2M | |
| Other Liab | 8.7M | 13.3M | 14.3M | 15.4M | 17.7M | 18.6M | |
| Net Tangible Assets | 284.6M | 480.6M | 983.4M | 610.4M | 701.9M | 394.5M |
HUTCHMED China Key Income Statement Accounts
An income statement is very similar to a cash flow statement, but instead of showing net revenue minus expenses, it only includes earnings before interest and taxes (EBIT). This number does not have all of the same line items that are on a cash flow statement, but it leaves out non-cash expenses like depreciation and amortization. For example, if you bought $100 worth of goods from Walmart (WMT) using your debit card that has an interest rate of 20%, then paid off the balance at the end of the month with a credit card that charges 30% interest, you would have an income statement showing EBIT of $80 because your expenses are lower than the amount that went into your pocket.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Interest Expense | 787K | 592K | 652K | 759K | 872.9K | 879.4K | |
| Total Revenue | 228.0M | 356.1M | 426.4M | 838.0M | 963.7M | 1.0B | |
| Gross Profit | 39.5M | 97.9M | 115.3M | 453.6M | 521.6M | 547.7M | |
| Operating Income | (188.9M) | (336.5M) | (409.8M) | 18.4M | 16.5M | 17.4M | |
| Ebit | (188.9M) | (336.5M) | (409.8M) | 59.1M | 53.2M | 55.8M | |
| Research Development | 111.2M | 207.4M | 267.6M | 302.0M | 347.3M | 364.7M | |
| Ebitda | (182.9M) | (329.3M) | (401.1M) | 67.3M | 60.5M | 63.6M | |
| Cost Of Revenue | 188.5M | 258.2M | 311.1M | 384.4M | 442.1M | 464.2M | |
| Income Before Tax | (189.7M) | (215.7M) | (410.4M) | 105.6M | 95.0M | 99.8M | |
| Net Income | (194.6M) | (227.7M) | (410.1M) | 100.8M | 90.7M | 95.2M | |
| Income Tax Expense | 4.8M | 11.9M | (283K) | 4.5M | 5.2M | 3.1M | |
| Minority Interest | 34.8M | (27.6M) | (449K) | (314K) | (361.1K) | (343.0K) | |
| Tax Provision | 4.8M | 11.9M | (283K) | 4.5M | 5.2M | 4.9M | |
| Net Interest Income | 2.4M | 1.5M | 8.9M | 35.4M | 40.7M | 42.7M | |
| Interest Income | 3.2M | 2.1M | 9.6M | 36.1M | 41.6M | 43.6M |
HUTCHMED China Key Cash Accounts
Cash flow analysis captures how much money flows into and out of HUTCHMED China. It measures of how well HUTCHMED is doing because it can show the actual money that comes into and out of the Company from sales instead of measuring expenses against revenue to determine earnings. You have to read the cash flow statement in three sections. The first section shows how much money HUTCHMED China brought in, usually known as net revenue or sales. This is different from earnings because it does not include expenses when determining net revenue for use on this part of the cash flow statement. Next, are operating activities, which show how much money HUTCHMED had leftover after paying for its expenses. This number can be calculated in two ways: by subtracting the total of all operating expenses from net revenue or by adding up changes to cash and other assets or liabilities on this part of the statement. The third section is about investing activities, which shows what HUTCHMED China has done with the money that it received from the sale of assets or what it spent to acquire new ones. This section can be broken down into two parts: investing in existing businesses (in other words, buying more stock) and investing in non-business activities like paying off debt or making acquisitions.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Change To Inventory | (3.6M) | (16.0M) | (21.2M) | 4.1M | 3.7M | 3.9M | |
| Change In Cash | 114.5M | 141.9M | (64.3M) | (29.7M) | (34.1M) | (32.4M) | |
| Free Cash Flow | (81.6M) | (221.0M) | (305.3M) | 186.6M | 168.0M | 176.4M | |
| Depreciation | 6.1M | 7.2M | 8.7M | 8.2M | 9.4M | 9.9M | |
| Other Non Cash Items | (2.1M) | (3.7M) | (6.2M) | 1.6M | 1.4M | 1.5M | |
| Capital Expenditures | 19.6M | 16.8M | 36.7M | 32.6M | 37.5M | 39.4M | |
| Net Income | (115.5M) | (167.0M) | (360.4M) | 101.1M | 91.0M | 95.5M | |
| End Period Cash Flow | 235.6M | 377.5M | 313.3M | 283.6M | 326.1M | 342.4M | |
| Investments | (103.5M) | (275.5M) | 296.6M | (291.1M) | (262.0M) | (248.9M) | |
| Net Borrowings | (4.6M) | (116K) | (579K) | (9.2M) | (8.3M) | (7.8M) | |
| Change To Netincome | 3.9M | 28.3M | (49.3M) | 24.9M | 22.4M | 23.5M |
HUTCHMED Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining HUTCHMED China's current stock value. Our valuation model uses many indicators to compare HUTCHMED China value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across HUTCHMED China competition to find correlations between indicators driving HUTCHMED China's intrinsic value. More Info.HUTCHMED China is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the HUTCHMED China's earnings, one of the primary drivers of an investment's value.HUTCHMED China Systematic Risk
HUTCHMED China's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. HUTCHMED China volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The function did not generate any output. Please change time horizon or modify your input parameters. The output start index for this execution was one with a total number of output elements of sixty. The Beta measures systematic risk based on how returns on HUTCHMED China correlated with the market. If Beta is less than 0 HUTCHMED China generally moves in the opposite direction as compared to the market. If HUTCHMED China Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one HUTCHMED China is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of HUTCHMED China is generally in the same direction as the market. If Beta > 1 HUTCHMED China moves generally in the same direction as, but more than the movement of the benchmark.
HUTCHMED China Total Assets Over Time
HUTCHMED China January 22, 2025 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of HUTCHMED China help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of HUTCHMED China. We use our internally-developed statistical techniques to arrive at the intrinsic value of HUTCHMED China based on widely used predictive technical indicators. In general, we focus on analyzing HUTCHMED Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build HUTCHMED China's daily price indicators and compare them against related drivers.
| Information Ratio | (0.08) | |||
| Maximum Drawdown | 17.96 | |||
| Value At Risk | (4.48) | |||
| Potential Upside | 6.08 |
Complementary Tools for HUTCHMED Stock analysis
When running HUTCHMED China's price analysis, check to measure HUTCHMED China's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HUTCHMED China is operating at the current time. Most of HUTCHMED China's value examination focuses on studying past and present price action to predict the probability of HUTCHMED China's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HUTCHMED China's price. Additionally, you may evaluate how the addition of HUTCHMED China to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated |